Literature DB >> 22081311

SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues.

Sungpil Yoon1, Young-Su Yi, Sang Soo Kim, Ju-Hwa Kim, Won Sang Park, Suk Woo Nam.   

Abstract

In the present study, we investigated mRNA expression patterns of both SOCS5 and SOCS6 in various normal and cancer tissues using a commercially available Cancer Profiling Array. We found that SOCS5 and SOCS6 had similar expression patterns in most cancer and healthy individuals, suggesting that these two genes are transcriptionally co-regulated. Tissue-specific up- or down-regulation of SOCS5 and SOCS6 was observed in several cancer tissues. Most importantly, thyroid gland cancer tissues exhibited large reductions of both SOCS5 and SOCS6 expressions. In addition, mRNA and protein levels of SOCS6 were down-regulated in liver cancer tissues. The results from our study may contribute to understanding SOCS5 and SOCS6 expression regulation in various cancer tissues, and show that these two factors may be used for diagnosing cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081311     DOI: 10.1007/s13277-011-0264-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

Review 1.  Suppressors of cytokine signaling and immunity.

Authors:  Masato Kubo; Toshikatsu Hanada; Akihiko Yoshimura
Journal:  Nat Immunol       Date:  2003-12       Impact factor: 25.606

2.  Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform.

Authors:  Sang Soo Kim; Liu Cao; Sung-Chul Lim; Cuiling Li; Rui-Hong Wang; Xiaoling Xu; Richard Bachelier; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response.

Authors:  E Puxeddu; J A Knauf; M A Sartor; N Mitsutake; E P Smith; M Medvedovic; C R Tomlinson; S Moretti; J A Fagin
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

Review 4.  Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.

Authors:  Lynda A O'Sullivan; Clifford Liongue; Rowena S Lewis; Sarah E M Stephenson; Alister C Ward
Journal:  Mol Immunol       Date:  2007-01-17       Impact factor: 4.407

5.  Twenty proteins containing a C-terminal SOCS box form five structural classes.

Authors:  D J Hilton; R T Richardson; W S Alexander; E M Viney; T A Willson; N S Sprigg; R Starr; S E Nicholson; D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

6.  Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway.

Authors:  E S Park; H Kim; J M Suh; S J Park; S H You; H K Chung; K W Lee; O Y Kwon; B Y Cho; Y K Kim; H K Ro; J Chung; M Shong
Journal:  Mol Endocrinol       Date:  2000-05

7.  Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.

Authors:  Walid Sasi; Wen G Jiang; Anup Sharma; Kefah Mokbel
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

8.  Defective interleukin-4/Stat6 activity correlates with increased constitutive expression of negative regulators SOCS-3, SOCS-7, and CISH in colon cancer cells.

Authors:  Xiao Hong Liu; Shuang Bing Xu; Jia Yuan; Ben Hui Li; Yan Zhang; Qin Yuan; Pin Dong Li; Feng Li; Wen Jie Zhang
Journal:  J Interferon Cytokine Res       Date:  2009-12       Impact factor: 2.607

9.  Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7.

Authors:  Brandon E Kremer; Laura A Adang; Ian G Macara
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

Review 10.  Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins.

Authors:  Ioannis D Dimitriou; Liliana Clemenza; Andrew J Scotter; Grace Chen; Fiona M Guerra; Robert Rottapel
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

View more
  14 in total

Review 1.  Cell regulation by phosphotyrosine-targeted ubiquitin ligases.

Authors:  Jonathan A Cooper; Tomonori Kaneko; Shawn S C Li
Journal:  Mol Cell Biol       Date:  2015-03-16       Impact factor: 4.272

2.  miR-24-3p stimulates migration, invasion and proliferation of prostate cancer cells by targeting suppressor of cytokine signaling 6.

Authors:  Yang Lin; Huifang Cao; Yuxin Tian; Xinping Yang; Changdong Zhou; Qifu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  SOCS proteins in development and disease.

Authors:  Monique C Trengove; Alister C Ward
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

4.  Inhibition of miR-1298-5p attenuates sepsis lung injury by targeting SOCS6.

Authors:  Jian Ma; Li-Yun Xu; Qiu-Hong Sun; Xiao-Yu Wan
Journal:  Mol Cell Biochem       Date:  2021-06-07       Impact factor: 3.396

5.  Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.

Authors:  Xinyu Qiu; Jianyong Zheng; Xiaodong Guo; Xingchun Gao; Hui Liu; Yanyang Tu; Yongsheng Zhang
Journal:  Mol Cell Biochem       Date:  2013-03-11       Impact factor: 3.396

Review 6.  SOCS6 is a selective suppressor of receptor tyrosine kinase signaling.

Authors:  Nuzhat N Kabir; Jianmin Sun; Lars Rönnstrand; Julhash U Kazi
Journal:  Tumour Biol       Date:  2014-08-30

7.  Expression of SOCSs in human prostate cancer and their association in prognosis.

Authors:  Jian-guo Zhu; Qi-shan Dai; Zhao-dong Han; Hui-chan He; Ru-jun Mo; Guo Chen; Yan-fei Chen; Yong-ding Wu; Sheng-bang Yang; Fu-neng Jiang; Wei-hong Chen; Zhao-lin Sun; Wei-de Zhong
Journal:  Mol Cell Biochem       Date:  2013-05-11       Impact factor: 3.396

Review 8.  The role of suppressors of cytokine signalling in human neoplasms.

Authors:  Walid Sasi; Anup K Sharma; Kefah Mokbel
Journal:  Mol Biol Int       Date:  2014-03-16

9.  Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer.

Authors:  E Letellier; M Schmitz; K Baig; N Beaume; C Schwartz; S Frasquilho; L Antunes; N Marcon; P V Nazarov; L Vallar; J Even; S Haan
Journal:  Br J Cancer       Date:  2014-07-15       Impact factor: 7.640

10.  Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.

Authors:  Mingyu Sun; Chuangang Tang; Jun Liu; Wenli Jiang; Haifeng Yu; Fang Dong; Caiguo Huang; Youlutuziayi Rixiati
Journal:  BMC Cancer       Date:  2021-06-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.